These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
255 related articles for article (PubMed ID: 27884713)
1. Paclitaxel-loaded polymeric nanoparticles combined with chronomodulated chemotherapy on lung cancer: In vitro and in vivo evaluation. Hu J; Fu S; Peng Q; Han Y; Xie J; Zan N; Chen Y; Fan J Int J Pharm; 2017 Jan; 516(1-2):313-322. PubMed ID: 27884713 [TBL] [Abstract][Full Text] [Related]
2. In vivo synergistic anti-tumor effect of paclitaxel nanoparticles combined with radiotherapy on human cervical carcinoma. Yu Y; Xu S; You H; Zhang Y; Yang B; Sun X; Yang L; Chen Y; Fu S; Wu J Drug Deliv; 2017 Nov; 24(1):75-82. PubMed ID: 28155566 [TBL] [Abstract][Full Text] [Related]
3. Paclitaxel-loaded polymeric nanoparticles based on α-tocopheryl succinate for the treatment of head and neck squamous cell carcinoma: Riestra-Ayora J; Sánchez-Rodríguez C; Palao-Suay R; Yanes-Díaz J; Martín-Hita A; Aguilar MR; Sanz-Fernández R Drug Deliv; 2021 Dec; 28(1):1376-1388. PubMed ID: 34180747 [TBL] [Abstract][Full Text] [Related]
4. Polymeric Nanomedicine for Combined Gene/Chemotherapy Elicits Enhanced Tumor Suppression. Xu B; Xia S; Wang F; Jin Q; Yu T; He L; Chen Y; Liu Y; Li S; Tan X; Ren K; Yao S; Zeng J; Song X Mol Pharm; 2016 Feb; 13(2):663-76. PubMed ID: 26695934 [TBL] [Abstract][Full Text] [Related]
5. Chronic chemotherapy with paclitaxel nanoparticles induced apoptosis in lung cancer in vitro and in vivo. Zhao X; Fan J; Wu P; Wei C; Chen Q; Ming Z; Yan J; Yang L Int J Nanomedicine; 2019; 14():1299-1309. PubMed ID: 30863062 [TBL] [Abstract][Full Text] [Related]
6. Development of paclitaxel loaded pegylated gelatin targeted nanoparticles for improved treatment efficacy in non-small cell lung cancer (NSCLC): an in vitro and in vivo evaluation study. Gu M; Luan J; Song K; Qiu C; Zhang X; Zhang M Acta Biochim Pol; 2021 Aug; 68(4):583-591. PubMed ID: 34355554 [TBL] [Abstract][Full Text] [Related]
7. Paclitaxel-loaded PCL-TPGS nanoparticles: in vitro and in vivo performance compared with Abraxane®. Bernabeu E; Helguera G; Legaspi MJ; Gonzalez L; Hocht C; Taira C; Chiappetta DA Colloids Surf B Biointerfaces; 2014 Jan; 113():43-50. PubMed ID: 24060929 [TBL] [Abstract][Full Text] [Related]
8. Folate-modified lipid-polymer hybrid nanoparticles for targeted paclitaxel delivery. Zhang L; Zhu D; Dong X; Sun H; Song C; Wang C; Kong D Int J Nanomedicine; 2015; 10():2101-14. PubMed ID: 25844039 [TBL] [Abstract][Full Text] [Related]
9. A novel nanoformulation of PLGA with high non-ionic surfactant content improves in vitro and in vivo PTX activity against lung cancer. Jiménez-López J; El-Hammadi MM; Ortiz R; Cayero-Otero MD; Cabeza L; Perazzoli G; Martin-Banderas L; Baeyens JM; Prados J; Melguizo C Pharmacol Res; 2019 Mar; 141():451-465. PubMed ID: 30634051 [TBL] [Abstract][Full Text] [Related]
10. A reconstituted thermosensitive hydrogel system based on paclitaxel-loaded amphiphilic copolymer nanoparticles and antitumor efficacy. Liang Y; Dong C; Zhang J; Deng L; Dong A Drug Dev Ind Pharm; 2017 Jun; 43(6):972-979. PubMed ID: 28121206 [TBL] [Abstract][Full Text] [Related]
11. Cancer cell membrane-camouflaged paclitaxel/PLGA nanoparticles for targeted therapy against lung cancer. Zhou J; Wan S; Wu Y; Hu H; Liu Y; Liao Z; Xu M; Wu J; Fan Q Biomed Pharmacother; 2024 Aug; 177():117102. PubMed ID: 38991303 [TBL] [Abstract][Full Text] [Related]
12. Peptide-functionalized and high drug loaded novel nanoparticles as dual-targeting drug delivery system for modulated and controlled release of paclitaxel to brain glioma. Di Mauro PP; Cascante A; Brugada Vilà P; Gómez-Vallejo V; Llop J; Borrós S Int J Pharm; 2018 Dec; 553(1-2):169-185. PubMed ID: 30321641 [TBL] [Abstract][Full Text] [Related]
13. Paclitaxel-loaded poly(glycolide-co-ε-caprolactone)-b-D-α-tocopheryl polyethylene glycol 2000 succinate nanoparticles for lung cancer therapy. Zhao T; Chen H; Dong Y; Zhang J; Huang H; Zhu J; Zhang W Int J Nanomedicine; 2013; 8():1947-57. PubMed ID: 23696703 [TBL] [Abstract][Full Text] [Related]
14. Paclitaxel-loaded star-shaped copolymer nanoparticles for enhanced malignant melanoma chemotherapy against multidrug resistance. Su Y; Hu J; Huang Z; Huang Y; Peng B; Xie N; Liu H Drug Des Devel Ther; 2017; 11():659-668. PubMed ID: 28293102 [TBL] [Abstract][Full Text] [Related]
15. Well-Defined Redox-Sensitive Polyethene Glycol-Paclitaxel Prodrug Conjugate for Tumor-Specific Delivery of Paclitaxel Using Octreotide for Tumor Targeting. Yin T; Wu Q; Wang L; Yin L; Zhou J; Huo M Mol Pharm; 2015 Aug; 12(8):3020-31. PubMed ID: 26086430 [TBL] [Abstract][Full Text] [Related]
16. Paclitaxel-loaded trimethyl chitosan-based polymeric nanoparticle for the effective treatment of gastroenteric tumors. Song RF; Li XJ; Cheng XL; Fu AR; Wang YH; Feng YJ; Xiong Y Oncol Rep; 2014 Oct; 32(4):1481-8. PubMed ID: 25051142 [TBL] [Abstract][Full Text] [Related]
17. Efficient antitumor effect of co-drug-loaded nanoparticles with gelatin hydrogel by local implantation. Zhang H; Tian Y; Zhu Z; Xu H; Li X; Zheng D; Sun W Sci Rep; 2016 May; 6():26546. PubMed ID: 27226240 [TBL] [Abstract][Full Text] [Related]
18. Co-delivery of cisplatin and paclitaxel by folic acid conjugated amphiphilic PEG-PLGA copolymer nanoparticles for the treatment of non-small lung cancer. He Z; Huang J; Xu Y; Zhang X; Teng Y; Huang C; Wu Y; Zhang X; Zhang H; Sun W Oncotarget; 2015 Dec; 6(39):42150-68. PubMed ID: 26517524 [TBL] [Abstract][Full Text] [Related]
19. Formulation and evaluation of paclitaxel-loaded polymeric nanoparticles composed of polyethylene glycol and polylactic acid block copolymer. Araki T; Kono Y; Ogawara K; Watanabe T; Ono T; Kimura T; Higaki K Biol Pharm Bull; 2012; 35(8):1306-13. PubMed ID: 22863930 [TBL] [Abstract][Full Text] [Related]
20. Enhanced anti-glioblastoma efficacy by PTX-loaded PEGylated poly(ɛ-caprolactone) nanoparticles: In vitro and in vivo evaluation. Xin H; Chen L; Gu J; Ren X; Wei Z; Luo J; Chen Y; Jiang X; Sha X; Fang X Int J Pharm; 2010 Dec; 402(1-2):238-47. PubMed ID: 20934500 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]